Business Description
Pharmacolog i Uppsala AB
ISIN : SE0019071812
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 98.8 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.01 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.3 | |||||
3-Year EBITDA Growth Rate | 35 | |||||
3-Year EPS without NRI Growth Rate | 27 | |||||
3-Year FCF Growth Rate | 35.7 | |||||
3-Year Book Growth Rate | -49.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30 | |||||
9-Day RSI | 36.6 | |||||
14-Day RSI | 42.68 | |||||
6-1 Month Momentum % | 94.86 | |||||
12-1 Month Momentum % | -69.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.28 | |||||
Quick Ratio | 2.14 | |||||
Cash Ratio | 1.31 | |||||
Days Inventory | 61.95 | |||||
Days Sales Outstanding | 83.87 | |||||
Days Payable | 128.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -60.7 | |||||
Shareholder Yield % | -111.1 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.85 | |||||
Operating Margin % | -186.13 | |||||
Net Margin % | -183.95 | |||||
FCF Margin % | -171.42 | |||||
ROE % | -161.41 | |||||
ROA % | -113.19 | |||||
ROIC % | -236.86 | |||||
ROC (Joel Greenblatt) % | -4639.54 | |||||
ROCE % | -160.45 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.3 | |||||
PB Ratio | 0.77 | |||||
Price-to-Tangible-Book | 1.05 | |||||
EV-to-EBIT | -0.27 | |||||
EV-to-EBITDA | -0.27 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-FCF | -0.32 | |||||
Price-to-Net-Current-Asset-Value | 1.19 | |||||
Price-to-Net-Cash | 4.74 | |||||
Earnings Yield (Greenblatt) % | -376.23 | |||||
FCF Yield % | -165.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharmacolog i Uppsala AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 9.936 | ||
EPS (TTM) (kr) | -17.955 | ||
Beta | 0 | ||
Volatility % | 141.29 | ||
14-Day RSI | 42.68 | ||
14-Day ATR (kr) | 0.004013 | ||
20-Day SMA (kr) | 0.09892 | ||
12-1 Month Momentum % | -69.07 | ||
52-Week Range (kr) | 0.0204 - 0.556316 | ||
Shares Outstanding (Mil) | 108.52 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmacolog i Uppsala AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmacolog i Uppsala AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Pharmacolog i Uppsala AB Frequently Asked Questions
What is Pharmacolog i Uppsala AB(OSTO:PERP B)'s stock price today?
When is next earnings date of Pharmacolog i Uppsala AB(OSTO:PERP B)?
Does Pharmacolog i Uppsala AB(OSTO:PERP B) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |